This unit describes how to conduct a clinical assessment before uterine evacuation with medicines and/or MVA, including for postabortion care. Additionally, it reviews medical eligibility, contraindications, and precautions for uterine evacuation with medicines and/or MVA.
This unit explains recommended mifepristone and/or misoprostol regimens, the essential information to provide, and the expected effects, side effects, and warning signs of uterine evacuation with mifepristone and/or misoprostol. Additionally, it describes the potential complications of uterine evacuation with mifepristone and/or misoprostol and complications management as well as post-procedure care and follow-up.
This unit discusses the facts and features of the Ipas MVA Plus® and Ipas EasyGrip Cannulae® and how to process MVA instruments in accordance with local regulations and with locally available products/systems. Additionally, it reviews the steps of providing uterine evacuation with Ipas MVA Plus®, how to resolve common technical problems, and how to develop a pain management plan with the woman that is sensitive to her situation. Lastly, the unit discusses elements of post-procedure care and referrals to other reproductive health services.
This unit describes how to identify signs and symptoms of severe abortion-related complications, including shock and management for complications.
This unit describes monitoring and its importance in improving abortion-related services; the general steps for integrating abortion-related services into existing sexual and reproductive health programs; and developing a work plan to ensure effective supply management, the sustainability of uterine evacuation services, and ongoing training/mentoring needs.
This unit analyzes how the training met participants’ expectations and the course objectives.
Participants of Uterine Evacuation in Crisis Settings Using Medications and Manual Vacuum Aspiration should review this list of resources and references from IAWG and our external partners.
The objective of this guideline is to present the complete set of all WHO recommendations and best practice statements relating to abortion. While legal, regulatory, policy and service-delivery contexts may vary from country to country, the recommendations and best practices described in this document aim to enable evidence-based decision-making with respect to quality abortion care.
This report presents the findings on the CARE’s Inspiring Married Adolescent Girls to Imagine New Empowered Futures (IMAGINE) intervention in Bangladesh and Niger. The goals of the IMAGINE program were broadly to provide knowledge and resources to married adolescent girls to improve a wide variety of health and economic outcomes.
The Women Deliver 2023 Conference (WD2023) will take place in-person in Kigali, Rwanda, as well as virtually, from 17-20 July 2023. It expects to convene 6,000 people in Kigali and 200,000+ people online through the virtual Conference and six-month Global Dialogue leading up to the Conference.
To ensure the most vulnerable populations are meaningfully integrated into the self-care movement, the IAWG Self-Care Task Team, the International Rescue Committee, and the Self-Care Trailblazer Group co-created a Global Call to Action for Sexual and Reproductive Health Self-Care in Humanitarian and Fragile Settings.
Building on a recent global assessment of SRH self-care in humanitarian settings to address this gap, the International Rescue Committee, SCTG and IAWG Self-Care Task Team are launching a Global Call-To-Action for Sexual and Reproductive Health Self-Care in Humanitarian and Fragile Settings.
